These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 31019405)
21. Residual Enoxaparin Activity, Anti-Xa Levels, and Concerns About the American Society of Regional Anesthesia and Pain Medicine Anticoagulation Guidelines. Henshaw DS; Turner JD; Forest DJ; Thompson GR; Weller RS Reg Anesth Pain Med; 2017; 42(4):432-436. PubMed ID: 28492441 [TBL] [Abstract][Full Text] [Related]
22. The use of anti-factor Xa monitoring in a selection of patients receiving enoxaparin at a large academic medical center. Sacha GL; Greenlee KM; Ketz JM J Thromb Thrombolysis; 2016 Nov; 42(4):479-85. PubMed ID: 27256341 [TBL] [Abstract][Full Text] [Related]
23. Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study. Lee YR; Palmere PJ; Burton CE; Benavides TM Clin Drug Investig; 2020 Jan; 40(1):33-40. PubMed ID: 31625111 [TBL] [Abstract][Full Text] [Related]
24. Trauma patients with lower extremity and pelvic fractures: Should anti-factor Xa trough level guide prophylactic enoxaparin dose? Dhillon NK; Smith EJT; Gillette E; Mason R; Barmparas G; Gewertz BL; Ley EJ Int J Surg; 2018 Mar; 51():128-132. PubMed ID: 29367044 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of enoxaparin dosing requirements in infants and children. Better dosing to achieve therapeutic levels. Bauman ME; Belletrutti MJ; Bajzar L; Black KL; Kuhle S; Bauman ML; Patricia Massicotte M Thromb Haemost; 2009 Jan; 101(1):86-92. PubMed ID: 19132193 [TBL] [Abstract][Full Text] [Related]
26. Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting It Right? Kufel WD; Seabury RW; Darko W; Probst LA; Miller CD Hosp Pharm; 2017 Mar; 52(3):214-220. PubMed ID: 28439136 [No Abstract] [Full Text] [Related]
27. Evaluation of Enoxaparin Dosing as a Risk Factor for Bleeding in Lung Transplant Recipients. Sofjan AK; Iuppa JA; Bain KB; Deal EN; Witt CA; Hachem RR; Yusen RD Ann Pharmacother; 2016 Oct; 50(10):824-31. PubMed ID: 27363845 [TBL] [Abstract][Full Text] [Related]
28. Novel uses of insulin syringes to reduce dosing errors: a retrospective chart review of enoxaparin whole milligram dosing. Bauman ME; Black KL; Bauman ML; Belletrutti M; Bajzar L; Massicotte MP Thromb Res; 2009 Apr; 123(6):845-7. PubMed ID: 19038418 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of an enoxaparin dosing calculator using burn size and weight. Faraklas I; Ghanem M; Brown A; Cochran A J Burn Care Res; 2013; 34(6):621-7. PubMed ID: 24043245 [TBL] [Abstract][Full Text] [Related]
30. Effect of Exogenous Antithrombin Administration on Anti-Xa Levels in Infants Treated With Enoxaparin. Logston BB; Rodman EA; Dinh KL; Placencia JL; Moffett BS; Rios DR J Pediatr Pharmacol Ther; 2018; 23(4):315-319. PubMed ID: 30181723 [TBL] [Abstract][Full Text] [Related]
31. Retrospective evaluation of antithrombin III supplementation in neonates and infants receiving enoxaparin for treatment of thrombosis. Corder A; Held K; Oschman A Pediatr Blood Cancer; 2014 Jun; 61(6):1063-7. PubMed ID: 24375987 [TBL] [Abstract][Full Text] [Related]
35. Prophylactic Enoxaparin Adjusted by Anti-Factor Xa Peak Levels Compared with Recommended Thromboprophylaxis and Rates of Clinically Evident Venous Thromboembolism in Surgical Oncology Patients. Kramme K; Sarraf P; Munene G J Am Coll Surg; 2020 Mar; 230(3):314-321. PubMed ID: 31843692 [TBL] [Abstract][Full Text] [Related]
36. Degree of anticoagulation after one subcutaneous and one subsequent intravenous booster dose of enoxaparin: implications for patients with acute coronary syndromes undergoing early percutaneous coronary intervention. Levine GN; Ferrando T J Thromb Thrombolysis; 2004 Jun; 17(3):167-71. PubMed ID: 15353913 [TBL] [Abstract][Full Text] [Related]
37. Factors influencing enoxaparin anti-Xa activity in surgical critically ill patients. Vincent PD; Albert M; Champagne MC; Zikos T; Boulanger I; Blais L; Williamson DR J Crit Care; 2011 Aug; 26(4):347-51. PubMed ID: 21454037 [TBL] [Abstract][Full Text] [Related]
38. IV enoxaparin in pediatric and cardiac ICU patients. Cies JJ; Santos L; Chopra A Pediatr Crit Care Med; 2014 Feb; 15(2):e95-103. PubMed ID: 24335994 [TBL] [Abstract][Full Text] [Related]
39. Enoxaparin and antifactor Xa levels in pediatric acute burn patients. Brown A; Faraklas I; Ghanem M; Cochran A J Burn Care Res; 2013; 34(6):628-32. PubMed ID: 24043233 [TBL] [Abstract][Full Text] [Related]
40. Enoxaparin use in the neonatal intensive care unit: experience over 8 years. Malowany JI; Knoppert DC; Chan AK; Pepelassis D; Lee DS Pharmacotherapy; 2007 Sep; 27(9):1263-71. PubMed ID: 17723080 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]